The therapeutic potential of PD-1/PD-L1 blockade in smoking exposed emphysema
J. Kim (Seoul, Republic of Korea), N. Kim (Seoul, Republic of Korea), C. Shon (Seoul, Republic of Korea), J. Huh (Seoul, Republic of Korea), K. Han (Seoul, Republic of Korea), K. Kim (Suwon, Republic of Korea), S. Shin (Seoul, Republic of Korea), H. Park (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea)
Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Kim (Seoul, Republic of Korea), N. Kim (Seoul, Republic of Korea), C. Shon (Seoul, Republic of Korea), J. Huh (Seoul, Republic of Korea), K. Han (Seoul, Republic of Korea), K. Kim (Suwon, Republic of Korea), S. Shin (Seoul, Republic of Korea), H. Park (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea). The therapeutic potential of PD-1/PD-L1 blockade in smoking exposed emphysema. 2948
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: